Aptinyx

About:

Aptinyx Inc. is a biopharmaceutical company.

Website: http://www.aptinyx.com/

Twitter/X: AptinyxInc

Top Investors: Northwestern University, Adams Street Partners, National Institutes of Health, Bain Capital Life Sciences, Frazier Healthcare Partners

Description:

Aptinyx Inc. is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication. This mechanism has applicability across a number of CNS disorders. Our goal is to rapidly advance our most promising drug candidates into clinical development for indications with high unmet medical need.

Total Funding Amount:

$274M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Evanston, Illinois, United States

Founded Date:

2015-01-01

Contact Email:

corporate(AT)aptinyx.com

Founders:

Joseph Moskal

Number of Employees:

11-50

Last Funding Date:

2022-11-03

IPO Status:

Public

Industries:

© 2025 bioDAO.ai